Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
The Prostate|October 30, 2018
Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patientsTakeshi Sasaki, Omar E Franco, Kohshi Ohishi, et al.Anticancer Research|November 11, 2006
A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese populationTakuji Shibahara, Takehisa Onishi, Omar E Franco, et al.International Journal of Cancer|July 8, 2003
Altered methylation of multiple genes in carcinogenesis of the prostateMikio Yamanaka, Masatoshi Watanabe, Yasushi Yamada, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2020
[LEIOMYOSARCOMA ARISING FROM THE RENAL VEIN]Sho Sekito, Kohei Nishikawa, Takumi Kageyama, et al.Radiology|August 9, 2013
Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinomaHaruyuki Takaki, Norihito Soga, Hideki Kanda, et al.The Prostate|January 29, 2002
Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancersSatoru Takahashi, Shugo Suzuki, Shingo Inaguma, et al.Hinyokika Kiyo. Acta Urologica Japonica|June 3, 2020
[Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma]Taketomo Nishikawa, Yusuke Sugino, Shunsuke Owa, et al.Nephron|November 22, 2020
A Kidney Transplant Recipient with Recurrent Henoch-Schönlein Purpura Nephritis Successfully Treated with Steroid Pulse Therapy and Epipharyngeal Abrasive TherapyMika Fujimoto, Kan Katayama, Kouhei Nishikawa, et al.IJU Case Reports|September 9, 2021
A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapyShunsuke Owa, Takeshi Sasaki, Katsunori Uchida, et al.Cardiovascular and Interventional Radiology|February 28, 2006
Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experienceKoichiro Yamakado, Atsuhiro Nakatsuka, Shigeki Kobayashi, et al.Pageof 16